The foot in perspective

Diabetes/Metabolism Research and Reviews

Volumn 24, Issue SUPPL. 1, 2008, Pages

  Apelqvist, Jan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetic foot; Foot ulcers; Ischaemic foot ulcers; Neuro ischaemic ulcers; Neuropathic ulcers; Peripheral artery disease

Indexed keywords

ANTIINFECTIVE AGENT;

ANGIOPLASTY; ARTERY DISEASE; ATTITUDE TO HEALTH; ATTITUDE TO ILLNESS; COMORBIDITY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIABETIC FOOT; DIABETIC NEUROPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DISEASE SEVERITY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH ECONOMICS; HUMAN; INFECTION; ISCHEMIA; LONG TERM CARE; PLANTAR ULCER; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL ASPECT; REIMBURSEMENT; RISK FACTOR; SELF CARE; TREATMENT OUTCOME; WOUND CARE; WOUND HEALING;

ATTITUDE TO HEALTH; COST OF ILLNESS; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; DIABETIC FOOT; FOOT ULCER; HUMANS; INFECTION; PREVALENCE; QUALITY OF LIFE; REIMBURSEMENT MECHANISMS; TREATMENT OUTCOME;

EID: 44949206713     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.834     Document Type: Conference Paper

References (61)

1. Schaper NC, Apelqvist J, Bakker K. The international consensus and practical guidelines on the management and prevention of the diabetic foot. Curr Diab Rep 2003; 3: 475 -479.
2. International Working Group on the Diabetic Foot. International Consensus on the Diabetic Foot and Practical Guidelines on the Management and Prevention of the Diabetic Foot. IWGDF: Amsterdam, 1999.
3. International Consensus on the Diabetic Foot and Practical Guidelines on the Management and the Prevention of the Diabetic Foot. International Working Group on the Diabetic Foot, 2007; Amsterdam, on CD-ROM (www.idf.org/bookshop).
4. Prompers L, Huijberts M, Apelqvist J, et al, Baseline results from the Eurodiale study. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Diabetologia 2007; 50: 18-25.
5. Prompers L, Huijberts M, Apelqvist J, et al. Optimal organization of health care in diabetic foot disease: introduction to the Eurodiale study. Int J Low Extrem Wounds 2007; 6: 11-17.
6. Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 2006; 29: 1784-1787.
7. Annersten M, Eneroth M, Larsson J, Nyberg P, Thöme J, Apelqvist J. Complexity of factors related to outcome of neuropathic and neuroischemic/ischemic diabetic foot ulcers. In Abstract: 5th European Conference of The Diabetic Foot, Noordwijkerhout, 2007.
8. Apelqvist J. Wound healing in diabetes. Outcome and costs. Clin Podiatr Med Surg 1998; 15: 21-39.
9. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch Dermatol 2000; 136: 1531-1535.
10. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Diabetic neuropathic foot ulcers: the association of wound size, wound duration and wound grade on healing. Diabetes Care 2002; 25: 1835-1839.
11. Margolis DJ, Gelfand JM, Hoffstad O, Berlin JA. Surrogate end points for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 2003; 26: 1696-1700.
12. Marston WA. Risk factors associated with healing chronic diabetic foot ulcers: the importance of hyperglycaemia. Ostomy Wound Manage 2006; 52: 26-28.
13. Armstrong DG, Lavery LA, Harkless I.B. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998; 21: 855-859.
14. Beckert S, Witte M, Wicke C, Königsrainer A, Coerper S. A new wound-based severity score for diabetic foot ulcers. Diabetes Care 2006; 29: 988-992.
15. Muller I, De Graw W, Van Gerwin W, Bartelink M, Van Den Hoogen HJ, Rutten G. Foot ulceration and lower limb amputation in Dutch Primary Health Care. Diabetes Care 2002; 25: 570-574.
16. Zimny S, Schatz H, Pfohl M. The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers. Exp Clin Endocrinol Diabetes 2004; 112: 191-194.
17. Sheehan P, Jones P, Caselli A, Giurni J, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12 - week prospective trial. Diabetes Care 2003; 26: 1879-1882.
18. Jeffcoate WJ, van Houtum WH. Amputation as a marker of the quality of foot care in diabetes. Diabetologia 2004; 47: 2051-2058.
19. Adam DJ, Beard JD, Cleveland T, et al, BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925-1934.
20. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, on behalf of the TASC II Working Group. Intersociety consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45(Suppl. 1): S5-S67.
21. Faglia E, Mantero M, Caminiti M, et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentre study of 221 consecutive diabetic subjects. J Intern Med 2002; 252: 225-232.
22. Jacqueminet S, Hartemann-Heurtier A, Izzillo R, et al. Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors. Diabetes Metab 2005; 31: 370-375.
23. Apelqvist J, Eneroth M, Larsson J, Nyberg P, Thöme J. Factor related to short term outcome of neuroischemic/ischemic foot ulcer in diabetic patients with and without angioplasty. In Abstract (Oral Pres) the 5th International Symposium on the Diabetic Foot Noordwijkerhout. The Netherlands, 2007.
24. Lavery LA, Armstrong D, Wunderlich R, Mohler M, Wendel C, Lipsky B. Risk factors for loot infections in individuals with diabetes. Diabetes Care 2006; 29: 1288-1293.
25. Eneroth M, Larsson J, Apelqvist J. Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diabetes Complications 1999; 13: 254-263.
26. Nabuurs-Franssen MH, Huijberts MS, Nieuwenhuijzen Kruseman AC, Willems J. Schaper NC. Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia 2005;48:1 906-1910.
27. Carrington AL, Mawdsley SK, Morley M, Kincey J, Boulton AJ. Psychological status of diabetic patients with or without lower limb disability. Diabetes Res Clin Pract 1996; 32: 19-25.
28. Price P, Harding K. The impact of foot complications on health related quality of life in patients with diabetes. J Cutan Med Surg 2004; 4(1): 45-50.
29. Ragnarson-Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications 2000; 14: 235-241.
30. Vileikyte I. Diabetic Foot ulcers: a quality of life issue. Diabetes Metab Res Rev 2001; 17: 246-249.
31. Mills JL, Beckett WC, Taylor SM. The diabetic foot: consequences of delayed treatment and referral. South Med J 1991; 84: 970-974.
32. Macfarlane RM, Jeffcoate WJ. Factors contributing to the presentation of diabetic foot ulcers. Diabet Med 1997; 14: 867-870.
33. Walsh CH. A healed ulcer: what now? Diabet Med 1996; 13: 58-60.
34. Vileikyte I, Rubin RR, Leventhal H. Psychological aspects of diabetic neuropathic foot complications: an overview. Diabetes Metab Res Rev 2004; 20(S1): S13-S18.
35. Hjelm K. Nyberg P, Apelqvist J. The influence of beliefs about health and illness on foot care in diabetic subjects with severe foot lesions: a comparison of foreign and Swedish- born individuals. Clin Eff Nurs 2003; 7(1): 1-14.
36. Brod M. Quality of life issues in patients with diabetes and lower extremity ulcers: patients and care givers. Qual Life Res 1998; 7: 365-372.
37. Del Aguila MA, Reiber G, Koepsell T. How does provider and patient awareness of high-risk status for lower extremity amputation influence foot care practice? Diabetes Care 1994; 17: 1050-1054.
38. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot. Diabetes Metab Res Rev 2000; 16(S1): 73-83.
39. Aggleton P. Chalmers H. Nursing Models and Nursing Practice (2nd edn). MacMillan Press Ltd: Basingstoke, 2000.
40. McCormack B, Titchen A. Patient-centred practice: an emerging focus for nursing expertise. In Practice Knowledge in the Health Professions, Higgs J, Titchen A (eds). Butterwortk Heinemann: Oxford, 2001; 96-101.
41. Popoola MM. Paradigm shift. A clarion call for a holistic approach to chronic wound management. Adv Skin Wound Care 2000; 1: 47-48.
42. Dargis V, Pantelejeva O, Jonushaite A, Boulton A, Vileikyte L. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 1999; 22(9): 1428-1431.
43. McCabe CJ, Stevenson RC, Dolan AM. Evaluation of diabetic foot screening and protection programme. Diabet Med 1998; 15: 80-84.
44. Morris AD, McAlpine R, Steinke D, et al. Diabetes and lowerlimb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration, Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care 1998; 21: 738-743.
45. Pobjolainen T, Alaranta H. Epidemiology of lower limb amputees in Southern Finland in 1985 and trends since 1984. Prostet Ortot Int 1999; 23: 88-92.
46. Stiegler H, Standl E, Frank S, Mendler G. Failure of reducing lower extremity amputations in diabetic patients: results of two subsequent population based surveys 1990 and 1995 in Germany. Vasa 1998; 27: 10-14.
47. Trautner C, Haastert B, Giani G, Berger M. Incidence of lower limb Amputations and Diabetes. Diabetes Care 1996; 19: 1006-1009.
48. Trautner C, Haastert B, Spraul M, Giani G, Berger M. Unchanged incidence of lower limb amputations in german city 1990-1998. Diabetes Care 2001; 24: 855-859.
49. Eskelinen E, Eskelinen A, Alback A, Lepantalo M. Major amputation incidence decreases both in non-diabetic and in diabetic patients in Helsinki. Scand J Surg 2006; 95: 185-189.
50. Boulton AJM, Vileikyte L, Ragnarson-Tenvall G, Apelqvist A. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-1724.
51. Ragnarson-Tennvall G, Apelqvist J. prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia 2001; 44: 2077-2087.
52. Ortegon MM, Redekop WK, Niessen LW. Cost-effectiveness of prevention and treatment of the diabetic foot. Diabetes Care 2004;27: 901-907.
53. Rauner MS, Heidenberger K, Pesendorfer E-M. Using a Markov model to evaluate the cost-effectiveness of diabetic foot prevention strategies in Austria. In The Society for Modeling Simulation International, 2004; Vol. 2004, SCS.
54. Ragnarson Tennvall G, Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis 2004; 39(S2): S132-S139.
55. Van Acker K, Oleen-Burkey M, De Decker L. Cost and resource utilisation for prevention and treatment of foot lesions in a diabetic foot clinic in Belgium. Diabetes Res Clin Pract 2000; 50: 87-95.
56. van Houtum WH, Lavery L. Outcomes associated with diabetes related amputations in the Netherlands and in the state of California USA. J Intern Med 1996; 240: 227-231.
57. Jeffcoate W, Harding Y, Diabetic foot ulcers. Lancet 2003; 361: 1545-1551.
58. Apelqvist J, Larsson J, Agardh CD. Long term prognosis for diabetic patients with foot ulcer. J Int Med 1993; 233: 485-491.
59. Mantey I. Foster AVM, Spencer S. Edmonds ME. Why do foot ulcers recur in diabetic patients? Diabet Med 1999; 16: 245-249.
60. Connor H. Mahdi OZ. Repetitive ulceration in neuropathic patients. Diabetes Metab Res Rev 2004; 20(S1): S23-S28.
61. Apelqvist J. Annersten M. Eneroth M. Larsson J, Nyberg P. Thörne J. Factors related to long term outcome and recurrence of ulcers in diabetic patients with a previously healed foot ulcer. In Abstract (Oral Pres) 5th International Symposium on the Diabetic Foot Noordwijkerhout, The Netherlands, 2007.